Understanding rheumatoid arthritis to improve treatment outcomes
AIM-for-RA
This study is looking at the different changes in joint tissue that make rheumatoid arthritis unpredictable, with the goal of finding new ways to tailor treatments and help people manage their pain and improve their quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11042188 on NIH RePORTER |
What this research studies
This research investigates the complexities of rheumatoid arthritis (RA), a condition that causes inflammation and joint damage, leading to significant pain and disability. The team aims to identify the cellular and molecular variations in synovial tissue that contribute to the unpredictable nature of RA. By analyzing synovial biopsy tissues, they hope to uncover biomarkers that can help personalize treatment strategies and improve patient outcomes. The research involves collaboration among global experts to enhance the understanding of RA and develop innovative approaches to treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis, particularly those experiencing severe symptoms or inadequate responses to current treatments.
Not a fit: Patients with other forms of arthritis or those who do not have rheumatoid arthritis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with rheumatoid arthritis.
How similar studies have performed: Previous research has shown promise in using molecular analysis to improve treatment strategies for autoimmune diseases, indicating potential success for this innovative approach.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Anolik, Jennifer Howitt — University of Rochester
- Study coordinator: Anolik, Jennifer Howitt
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.